Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-09 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-08 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-06 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |